Merck is well-stocked on Keytruda as pharma tariffs loom, CEO says
Merck CEO Rob Davis told investors on Thursday that he’s confident in the company’s ability to protect its top-selling product from the potential impacts of industry-specific tariffs. Without going into much detail on the implications ...
Merck CEO Rob Davis told investors on Thursday that he’s confident in the company’s ability to protect its top-selling product from the potential impacts of industry-specific tariffs.
Without going into much detail on the implications ...
